Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart ventilators under the microscope: can automation save lives?

NCT ID NCT06655805

Knowledge-focused Sponsor: Hamilton Medical AG Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is observing 1,000 adults in intensive care who need breathing support from machines like ventilators or high-flow oxygen. Researchers want to see how well automated software settings keep patients safe and within recommended breathing ranges. No new treatment is being tested—just real-world data collection to improve future care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help improve automated ventilation software to make breathing support safer and more effective for ICU patients.
What could go wrong
This is an observational registry, not a treatment trial. It collects data but does not test a new therapy, so direct patient benefits are not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2024

Expected to finish

Dec 2030

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Consecutive patients admitted to the intensive care unit while on IMV or in need of HFNO, NIV lung support due to acute respiratory failure, or protection of the airway due to a non-respiratory life-threatening condition.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Age ≥ 18 years. Any patient in need of HFNO, NIV and IMV at some time during its ICU stay. Exclusion Criteria: Expected to be weaned from HFNO, NIV within 2 hours. Expected to be weaned and extubated from IMV without subsequent need of HFNO or NIV support within 2 hours. Expected to be transferred to another non-participating ICU within 2 hours. Moribund subject: death expected within 2 hours.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Respiratory insufficiency requiring mechanical ventilation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

respiratory failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Respiratory insufficiency requiring mechanical ventilation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    4 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • HOCH Health Ostschweiz, Clinics for Intensive Care Medicine, Medical ICU

    RECRUITING

    Sankt Gallen, St.Gallen, 9007, Switzerland

  • HOCH Health Ostschweiz, Clinics for Intensive Care Medicine, Surgical ICU

    RECRUITING

    Sankt Gallen, Canton of St. Gallen, 9007, Switzerland

  • Kantonsspital Chur

    RECRUITING

    Chur, Kanton Graubünden, 7000, Switzerland

  • Kantonsspital Winterthur, Zentrum für Intensivmedizin

    RECRUITING

    Winterthur, 8400, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.